Percutaneous Resection of Renal Pelvis and Calyceal Tumors

  • Majid EshghiEmail author
  • Joel Hillelsohn
  • Roger Yau


This chapter describes in details all the aspects of percutaneous management of renal pelvis tumors. These tumors are mostly low grade and bulky and the resection is with the intent of complete, curative and sometimes palliative purposes. Majority of these patients have compromised renal function or have significant co morbidities. The technical aspects of resection, follow up biopsy and surveillance are described with video samples of different stages. There will also be description of intracavitary treatment.


Upper tract TCC UCUT Resection of renal pelvic tumor Laser ablation renal pelvic tumor Percutaneous resection urothelial carcinoma Nephroscopic surveillance of tumor Intracavitary-topical chemotherapy 

Supplementary material

Video 22.1

The video clip demonstates deep cold cup biopsy of tumor and margin area (MP4 108385 kb)

Video 22.2

This video clip demonstrates insertion of scope and acute dilation for initial evaluation and inspection (MP4 50933 kb)

Video 22.3

This clip shows biopsy of the tumor area using a 12Fr mini scope (MP4 180629 kb)

Video 22.4

This clip shows application of the laser to the area of the tumor (MP4 116912 kb)

Video 22.5

Percutaneous resection of large renal pelvic tumor (MP4 104315 kb)


  1. 1.
    Iwaszko MR, Krambeck AE. Conservative management of upper tract transitional cell carcinoma. Indian J Urol. 2008;24:159.CrossRefPubMedPubMedCentralGoogle Scholar
  2. 2.
    Rouprêt M, Babjuk M, Compérat E, et al. European association of urology guidelines on upper urinary tract urothelial cell carcinoma: 2015 update. Eur Urol. 2015;68:868.CrossRefPubMedGoogle Scholar
  3. 3.
    Adamis S, Varkarakis J. Minimally invasive approach in the management of upper- urinary-tract tumours. Scand J Urol Nephrol. 2011;45:381.CrossRefPubMedGoogle Scholar
  4. 4.
    Fuglsig S, Krarup T. Percutaneous nephroscopic resection of renal pelvic tumors. Scand J Urol Nephrol Suppl. 1995;172:15.PubMedGoogle Scholar
  5. 5.
    Plancke HR, Strijbos WE, Delaere KP. Percutaneous endoscopic treatment of urothelial tumours of the renal pelvis. Br J Urol. 1995;75:736.CrossRefPubMedGoogle Scholar
  6. 6.
    Patel A, Soonawalla P, Shepherd SF, et al. Long-term outcome after percutaneous treatment of transitional cell carcinoma of the renal pelvis. J Urol. 1996;155:868.CrossRefPubMedGoogle Scholar
  7. 7.
    Martínez-Piñeiro JA, García Matres MJ, Martínez-Piñeiro L. Endourological treatment of upper tract urothelial carcinomas: analysis of a series of 59 tumors. J Urol. 1996;156:377.CrossRefPubMedGoogle Scholar
  8. 8.
    Clark PE, Streem SB, Geisinger MA. 13-year experience with percutaneous management of upper tract transitional cell carcinoma. J Urol. 1999;161:772.CrossRefPubMedGoogle Scholar
  9. 9.
    Goel MC, Mahendra V, Roberts JG. Percutaneous management of renal pelvic urothelial tumors: long-term followup. J Urol. 2003;169:925.CrossRefPubMedGoogle Scholar
  10. 10.
    Suh RS, Faerber GJ, Wolf JS. Predictive factors for applicability and success with endoscopic treatment of upper tract urothelial carcinoma. J Urol. 2003;170:2209.CrossRefPubMedGoogle Scholar
  11. 11.
    Palou J, Piovesan LF, Huguet J, et al. Percutaneous nephroscopic management of upper urinary tract transitional cell carcinoma: recurrence and long-term followup. J Urol. 2004;172:66.CrossRefPubMedGoogle Scholar
  12. 12.
    Cornu JN, Rouprêt M, Carpentier X, et al. Oncologic control obtained after exclusive flexible ureteroscopic management of upper urinary tract urothelial cell carcinoma. World J Urol. 2010;28:151.CrossRefPubMedGoogle Scholar
  13. 13.
    Rastinehad AR, Ost MC, Vanderbrink BA, et al. A 20-year experience with percutaneous resection of upper tract transitional carcinoma: is there an oncologic benefit with adjuvant bacillus Calmette Guérin therapy? Urology. 2009;73:27.CrossRefPubMedGoogle Scholar
  14. 14.
    Motamedinia P, Keheila M, Leavitt DA, et al. The expanded use of percutaneous resection for upper tract urothelial carcinoma: a 30-year comprehensive experience. J Endourol. 2015.Google Scholar
  15. 15.
    Cutress ML, Stewart GD, Zakikhani P, et al. Ureteroscopic and percutaneous management of upper tract urothelial carcinoma (UTUC): systematic review. BJU Int. 2012;110:614.CrossRefPubMedGoogle Scholar
  16. 16.
    Tasca A, Zattoni F. The case for a percutaneous approach to transitional cell carcinoma of the renal pelvis. J Urol. 1990;143:902.CrossRefPubMedGoogle Scholar
  17. 17.
    Rouprêt M, Traxer O, Tligui M, et al. Upper urinary tract transitional cell carcinoma: recurrence rate after percutaneous endoscopic resection. Eur Urol. 2007;51:709.CrossRefPubMedGoogle Scholar
  18. 18.
    Johnson GB, Fraiman M, Grasso M. Broadening experience with the retrograde endoscopic management of upper urinary tract urothelial malignancies. BJU Int. 2005;95 Suppl 2:110.CrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Chief Section of Endourology and Minimally Invasive Urology, Department of UrologyNew York Medical College, Westchester Medical Health NetworkValhallaUSA
  2. 2.Department of UrologyWestchester Medical Health Network/New York Medical CollegeValhallaUSA

Personalised recommendations